Staging amyotrophic lateral sclerosis: A new focus on progression.
暂无分享,去创建一个
P. Corcia | P. Couratier | G. Lautrette | P Corcia | P Couratier | S Beltran | G Lautrette | S Bakkouche | S. Beltran | S. Bakkouche | P. Couratier
[1] H. Braak,et al. Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis , 2018, Cortex.
[2] T. Hanafusa,et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS , 2006, Neurology.
[3] W. Robberecht,et al. The phenotypic variability of amyotrophic lateral sclerosis , 2014, Nature Reviews Neurology.
[4] A. Chiò,et al. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[5] A. Al-Chalabi,et al. Comparison of the King’s and MiToS staging systems for ALS , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[6] D. Consonni,et al. Amyotrophic lateral sclerosis: a comparison of two staging systems in a population‐based study , 2016, European journal of neurology.
[7] Lucette Lacomblez,et al. Progression in ALS is not linear but is curvilinear , 2010, Journal of Neurology.
[8] Robert H. Brown,et al. Amyotrophic Lateral Sclerosis. , 2017, The New England journal of medicine.
[9] A. Al-Chalabi,et al. Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[10] Ahmad Al Khleifat,et al. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study , 2018, The Lancet Neurology.
[11] A. Chiò,et al. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[12] John Q. Trojanowski,et al. Amyotrophic lateral sclerosis—a model of corticofugal axonal spread , 2013, Nature Reviews Neurology.
[13] F. Torny,et al. Échelles fonctionnelles de la sclérose latérale amyotrophique , 2006 .
[14] A. Al-Chalabi,et al. A proposed staging system for amyotrophic lateral sclerosis , 2012, Brain : a journal of neurology.
[15] Jung A Kim,et al. Socioeconomic costs of amyotrophic lateral sclerosis according to staging system , 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[16] A. Al-Chalabi,et al. Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[17] G. Giovannoni,et al. Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[18] A. Al-Chalabi,et al. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.